By PR Newswire
August 04, 2026 | 11:03
Yili Group hosted the 2026 World Dairy Industry Conference in Hohhot, Inner Mongolia, centred on the theme of technology-driven, partnership-oriented collaboration for a sustainable global dairy ecosystem.
By PR Newswire
August 04, 2026 | 11:00
Enzene launched NeX™, a transformative end-to-end partnership model enabling governments, institutions and biopharma organisations to establish cost-efficient, high-yielding local biomanufacturing capabilities.
By PR Newswire
August 04, 2026 | 10:52
WuXi AppTec, dual-listed under 603259.SH and 2359.HK, delivered strong first-half 2026 results and raised its full-year guidance, driven by greater customer product success under its CRDMO model.
By PR Newswire
August 03, 2026 | 16:12
MM Century, a Penang-based environmental management and circular economy company, won three Gold and one Silver award in the SME and Mid-Tier category at The Star ESG Positive Impact Awards Gala Night.
By PR Newswire
August 03, 2026 | 16:09
StarCharge was named the No. 1 microgrid brand at the 2026 GGII Energy Storage Industry Summit, with its proprietary technology and more than 300 global deployments underpinning its leadership position.
By PR Newswire
August 03, 2026 | 16:03
Robo.ai, listed on Nasdaq under ticker AIIO, appointed Dr Jasem Ibrahim Mansour Al-Mansory as Chief Executive Officer of its proposed subsidiary Alif Holding, an Abu Dhabi-headquartered intelligent industrial company.
By PR Newswire
August 03, 2026 | 15:57
ZF Group's aftermarket division partnered with MKN as the sole distributor for TRW products in Indonesia, strengthening the automotive components giant's presence in the country's aftermarket sector.
By PR Newswire
August 03, 2026 | 15:54
Hanon Systems, a global automotive thermal management supplier and subsidiary of Hankook & Company Group, announced its financial results for the second quarter of 2026.
By PR Newswire
August 03, 2026 | 15:49
Ridgetech, a Nasdaq-listed wholesale distributor of pharmaceutical and healthcare products in China, announced its financial results for the fiscal year ended 31 March 2026.
By PR Newswire
August 03, 2026 | 15:36
Ractigen Therapeutics received US FDA clearance for its Investigational New Drug application for RAG-1C, a first-in-class small activating RNA candidate to treat proliferative vitreoretinopathy.